These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 29850577)

  • 21. Circulating CD14+CD204+ cells predict postoperative recurrence in non-small-cell lung cancer patients.
    Maeda R; Ishii G; Neri S; Aoyagi K; Haga H; Sasaki H; Nagai K; Ochiai A
    J Thorac Oncol; 2014 Feb; 9(2):179-88. PubMed ID: 24419414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyr61 promotes CD204 expression and the migration of macrophages via MEK/ERK pathway in esophageal squamous cell carcinoma.
    Shigeoka M; Urakawa N; Nishio M; Takase N; Utsunomiya S; Akiyama H; Kakeji Y; Komori T; Koma Y; Yokozaki H
    Cancer Med; 2015 Mar; 4(3):437-46. PubMed ID: 25620088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of biological properties of intralymphatic tumor related to the development of lymph node metastasis in lung adenocarcinoma.
    Kirita K; Ishii G; Matsuwaki R; Matsumura Y; Umemura S; Matsumoto S; Yoh K; Niho S; Goto K; Ohmatsu H; Ohe Y; Nagai K; Ochiai A
    PLoS One; 2013; 8(12):e83537. PubMed ID: 24376714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic impact of M2 macrophages at neural invasion in patients with invasive ductal carcinoma of the pancreas.
    Sugimoto M; Mitsunaga S; Yoshikawa K; Kato Y; Gotohda N; Takahashi S; Konishi M; Ikeda M; Kojima M; Ochiai A; Kaneko H
    Eur J Cancer; 2014 Jul; 50(11):1900-8. PubMed ID: 24835032
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumour-associated CD204
    Sørensen MD; Kristensen BW
    Neuropathol Appl Neurobiol; 2022 Feb; 48(2):e12772. PubMed ID: 34713474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor-associated macrophages infiltration is associated with peritumoral lymphangiogenesis and poor prognosis in lung adenocarcinoma.
    Zhang BC; Gao J; Wang J; Rao ZG; Wang BC; Gao JF
    Med Oncol; 2011 Dec; 28(4):1447-52. PubMed ID: 20676804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Abundant tumor promoting stromal cells in lung adenocarcinoma with hypoxic regions.
    Nakamura H; Ichikawa T; Nakasone S; Miyoshi T; Sugano M; Kojima M; Fujii S; Ochiai A; Kuwata T; Aokage K; Suzuki K; Tsuboi M; Ishii G
    Lung Cancer; 2018 Jan; 115():56-63. PubMed ID: 29290263
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification in stage IB lung adenocarcinoma.
    Xu CH; Wang W; Wei Y; Hu HD; Zou J; Yan J; Yu LK; Yang RS; Wang Y
    Eur J Surg Oncol; 2015 Oct; 41(10):1430-6. PubMed ID: 26123994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination of protein coding and noncoding gene expression as a robust prognostic classifier in stage I lung adenocarcinoma.
    Akagi I; Okayama H; Schetter AJ; Robles AI; Kohno T; Bowman ED; Kazandjian D; Welsh JA; Oue N; Saito M; Miyashita M; Uchida E; Takizawa T; Takenoshita S; Skaug V; Mollerup S; Haugen A; Yokota J; Harris CC
    Cancer Res; 2013 Jul; 73(13):3821-32. PubMed ID: 23639940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High density of CD204-positive macrophages predicts worse clinical prognosis in patients with breast cancer.
    Miyasato Y; Shiota T; Ohnishi K; Pan C; Yano H; Horlad H; Yamamoto Y; Yamamoto-Ibusuki M; Iwase H; Takeya M; Komohara Y
    Cancer Sci; 2017 Aug; 108(8):1693-1700. PubMed ID: 28574667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ROR1 is a novel prognostic biomarker in patients with lung adenocarcinoma.
    Zheng YZ; Ma R; Zhou JK; Guo CL; Wang YS; Li ZG; Liu LX; Peng Y
    Sci Rep; 2016 Nov; 6():36447. PubMed ID: 27830754
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of intravascular tumor microenvironment features predicting the recurrence of pathological stage I lung adenocarcinoma.
    Kaseda K; Ishii G; Aokage K; Takahashi A; Kuwata T; Hishida T; Yoshida J; Kohno M; Nagai K; Ochiai A
    Cancer Sci; 2013 Sep; 104(9):1262-9. PubMed ID: 23786153
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined Evaluation of Tumor-Infiltrating CD8 + and FoxP3 + Lymphocytes Provides Accurate Prognosis in Stage IA Lung Adenocarcinoma.
    Kinoshita F; Takada K; Yamada Y; Oku Y; Kosai K; Ono Y; Tanaka K; Wakasu S; Oba T; Osoegawa A; Tagawa T; Shimokawa M; Oda Y; Mori M
    Ann Surg Oncol; 2020 Jun; 27(6):2102-2109. PubMed ID: 31773516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and transcriptional signatures of human CD204 reveal an applicable marker for the protumor phenotype of tumor-associated macrophages in breast cancer.
    He Y; Zhou S; Deng F; Zhao S; Chen W; Wang D; Chen X; Hou J; Zhang J; Zhang W; Ding L; Tang J; Zhou Z
    Aging (Albany NY); 2019 Dec; 11(23):10883-10901. PubMed ID: 31799941
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical Significance of Subcellular Localization of Maspin in Patients with Pathological Stage IA Lung Adenocarcinoma.
    Ohno T; Kubouchi Y; Wakahara M; Nosaka K; Sakabe T; Haruki T; Miwa K; Taniguchi Y; Nakamura H; Umekita Y
    Anticancer Res; 2018 May; 38(5):3001-3007. PubMed ID: 29715131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of scavenger receptor MARCO defines a targetable tumor-associated macrophage subset in non-small cell lung cancer.
    La Fleur L; Boura VF; Alexeyenko A; Berglund A; Pontén V; Mattsson JSM; Djureinovic D; Persson J; Brunnström H; Isaksson J; Brandén E; Koyi H; Micke P; Karlsson MCI; Botling J
    Int J Cancer; 2018 Oct; 143(7):1741-1752. PubMed ID: 29667169
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic Value of Macrophage Phenotypes in Resectable Non-Small Cell Lung Cancer Assessed by Multiplex Immunohistochemistry.
    Rakaee M; Busund LR; Jamaly S; Paulsen EE; Richardsen E; Andersen S; Al-Saad S; Bremnes RM; Donnem T; Kilvaer TK
    Neoplasia; 2019 Mar; 21(3):282-293. PubMed ID: 30743162
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The clinicopathological significance of Lgr5 expression in lung adenocarcinoma.
    Ryuge S; Sato Y; Jiang SX; Wang G; Kobayashi M; Nagashio R; Katono K; Iyoda A; Satoh Y; Masuda N
    Lung Cancer; 2013 Oct; 82(1):143-8. PubMed ID: 23915911
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extracapsular extension is a powerful prognostic factor in stage IIA-IIIA non-small cell lung cancer patients with completely resection.
    Liu W; Shao Y; Guan B; Hao J; Cheng X; Ji K; Wang K
    Int J Clin Exp Pathol; 2015; 8(9):11268-77. PubMed ID: 26617851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-terminal respiratory unit type lung adenocarcinoma has three distinct subtypes and is associated with poor prognosis.
    Sumiyoshi S; Yoshizawa A; Sonobe M; Kobayashi M; Sato M; Fujimoto M; Tsuruyama T; Date H; Haga H
    Lung Cancer; 2014 Jun; 84(3):281-8. PubMed ID: 24725383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.